The Prognostic Value of Log Odds of Positive Lymph Nodes in Early-Stage Esophageal Cancer Patients: A Study Based on the SEER Database and a Chinese Cohort

被引:6
作者
Xi, Kexing [1 ,2 ]
Chen, Wenyou [3 ]
Yu, Hui [4 ,5 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr,Dept Colorectal Surg, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr,State Key Lab Mol Oncol, Beijing 100021, Peoples R China
[3] Jinan Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou 510630, Peoples R China
[4] Sun Yat Sen Univ, Canc Ctr, Dept Thorac Surg, Guangzhou 510060, Peoples R China
[5] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China
关键词
SQUAMOUS-CELL CARCINOMA; METASTASIS CLASSIFICATION; PANCREATIC-CANCER; RATIO; SURVIVAL; NUMBER; LODDS; PN; STATISTICS; RESECTION;
D O I
10.1155/2021/8834912
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Early detection and timely treatment are important for improving the prognosis of esophageal cancer (EC). Identification of the prognostic risk factors could help us to discern the high-risk population. This study was aimed at exploring the prognostic significance of log odds of positive lymph nodes (LODDS) in early-stage EC patients. Methods. Patients who underwent esophagectomy and diagnosed as pathologic T1-2 N0 EC were reviewed between January 2005 and December 2015 from the Surveillance, Epidemiology, and End Results (SEER) database (the development cohort, n = 1004). The X-tile software was used to determine the optimal cutoff values of LODDS. A separate Chinese cohort including 245 patients (the validation cohort) was used to externally validate the results of the SEER database. Result. Patients were divided into two groups based on the cutoff points of LODDS: <-1.40 (LODDS1) and >=-1.40 (LODDS2). In the development cohort, the 5-year overall survival (OS) rate was 75.3% for patients in the LODDS1 group, compared with 67.5% for those in the LODDS2 group (P=0.002). In multivariate Cox analysis, LODDS was associated with OS significantly (hazard ratio (HR), 1.48; 95% confidence intervals (CI), 1.19-1.85). In the validation cohort, the 5-year OS rate was 76.6% for patients in the LODDS1 group, compared with 64.4% for those in the LODDS2 group (P=0.006). The HR value in multivariate Cox analysis for OS was 2.00 (95% CI, 1.26-3.18). Conclusion. LODDS was an important independent factor for survival in early-stage EC patients.
引用
收藏
页数:8
相关论文
共 25 条
  • [21] Does Surgery Improve Outcomes for Esophageal Squamous Cell Carcinoma? An Analysis Using the Surveillance Epidemiology and End Results Registry from 1998 to 2008
    Worni, Mathias
    Martin, Jeremiah
    Gloor, Beat
    Pietrobon, Ricardo
    D'Amico, Thomas A.
    Akushevich, Igor
    Berry, Mark F.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2012, 215 (05) : 643 - 651
  • [22] The role of surgery in the management of oesophageal cancer
    Wu, PC
    Posner, MC
    [J]. LANCET ONCOLOGY, 2003, 4 (08) : 481 - 488
  • [23] The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma
    Zhang, H-L
    Chen, L-Q
    Liu, R-L
    Shi, Y-T
    He, M.
    Meng, X-L
    Bai, S-X
    Ping, Y-M
    [J]. DISEASES OF THE ESOPHAGUS, 2010, 23 (01) : 53 - 58
  • [24] The prognostic value of lymph node ratio and log odds of positive lymph nodes in patients with lung adenocarcinoma
    Zhao, Yue
    Li, Guodong
    Zheng, Difan
    Jia, Ming
    Dai, Weixing
    Sun, Yihua
    Chen, Haiquan
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 153 (03) : 702 - +
  • [25] Number of Negative Lymph Nodes is Associated with Survival in Thoracic Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy
    Zhu, Zhengfei
    Chen, Haiquan
    Yu, Weiwei
    Fu, Xiaolong
    Xiang, Jiaqing
    Li, Hecheng
    Zhang, Yawei
    Sun, Menghong
    Wei, Qiao
    Zhao, Weixin
    Zhao, Kuaile
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (09) : 2857 - 2863